Access Vascular, Inc

Access Vascular develops venous access devices that significantly reduce the rate of complications like thrombosis and infection compared to devices in use today. AVI's first FDA-cleared product, HydroPICC, is a Peripherally Inserted Central Catheter that has demonstrated a 30x reduction in thrombus formation, the primary cause of venous access complications, versus the market leader.